Please wait

LOGO

 

Via EDGAR  
  November 19, 2007

United States Securities and Exchange Commission

Washington, DC 20549

Attention: Tabitha Aikens

 

Re:    Biovest International, Inc.
   Form 10-KSB for the Fiscal Year Ended September 30, 2006
   Form 10-Q for the Quarterly Period Ended December 31, 2006
   File No. 000-11480

Dear Ms. Aikens:

In response to your telephonic inquiry on behalf of the Staff made October 26, 2007 to our Director of Legal Affairs, David Moser, please accept the attached schedule (Exhibit C) which provides the requested analysis of the impact of both New Market Tax Credit transactions closed April and December 2006. This information serves as a supplement to the Company’s response to Comment No. 4 in the Staff’s correspondence dated July 27, 2007.

As indicated in the Company’s previous response to the Staff’s letter dated July 27, 2007, which was submitted on August 27, 2007, the Company feels that the effect of these changes as shown on Exhibit C are immaterial to its overall financial results.

We appreciate the Staff’s comments. If you or the Staff have any further comments or questions, please contact our Director of Legal Affairs, David Moser at (813) 864-2554, or our outside counsel, Barry Grossman, Esq. at (212) 370-1300 or bigrossman@egsllp.com.

 

Sincerely,
By:  

/s/ James A. McNulty

Name:   James A. McNulty
Title:   Chief Financial Officer

 


324 S Hyde Park Avenue Suite 350 Tampa, Florida 33606

www.biovest.com tel:813 864 2554 fax: 813 258 6912


Summary:

Deferred financing costs related to NMTC I financing were as follows:

 

Biovest Legal fees

   38,000    Related to Laurus loan and accounted for as debt, thus remain as deferred financing costs

Biovest legal fees

   130,000    these should instead have been deducted from Biovest APIC

VIE legal and accounting fees

   240,000    these should instead have been deducted from VIE APIC and thus be part of NCI in VIEs upon consolidation

Management Fee paid by VIEs

   360,000    these should instead have been shown as a prepaid asset on VIEs balance sheet, note this is already reflected as such in the Company's 06/30/07 Form 10-Q

Deferred financing costs related to NMTC II financing were as follows:

Biovest legal fees

   496,000    these should instead have been deducted from Biovest APIC

VIE legal and accounting fees

   185,000    these should instead have been deducted from VIE APIC and thus be part of NCI in VIEs upon consolidation

Management Fee paid by VIEs

   115,000    these should instead have been shown as a prepaid asset on VIEs balance sheet, note this is already reflected as such in the Company's 06/30/07 Form 10-Q


Biovest International, Inc.

Exhibit C

Debit/(Credit)

 

     Prepaid
Expenses
   Deferred
Financing
Costs
   

Non-

Controlling
Interest in
VIEs

    Accounts
Payable
    APIC     Accumulated
Deficit
    G&A
Expense
    Interest
Expense
   

Non-

Controlling
Interest in
Loss of
VIEs

   

Total

Assets

    Total
Liabilities
    Minority
Interest in
Cons Sub
    Total
Stockholders'
Deficit
    Net Loss  

3 mo ended 6/30/06:

                             

As previously reported

   142,000    729,000     (3,600,000 )   (1,458,000 )   (35,059,000 )   48,553,000     700,000     1,272,000     —       10,880,000     (14,068,000 )   (6,000,000 )   12,788,000     4,118,000  

adjustment

   348,000    (706,000 )   356,000     (45,000 )   130,000     (83,000 )   57,000     (24,000 )   (116,000 )   (358,000 )   (45,000 )   —       47,000     (83,000 )
                                                                                   

As restated

   490,000    23,000     (3,244,000 )   (1,503,000 )   (34,929,000 )   48,470,000     757,000     1,248,000     (116,000 )   10,522,000     (14,113,000 )   (6,000,000 )   12,835,000     4,035,000  
                                                                                   

% Difference

                      3.3 %   0.3 %   0.0 %   0.4 %   2.0 %

9 mo ended 6/30/06:

                             

As previously reported

   142,000    729,000     (3,600,000 )   (1,458,000 )   (35,059,000 )   48,553,000     2,446,000     1,498,000     —       10,880,000     (14,068,000 )   (6,000,000 )   12,788,000     9,910,000  

adjustment

   348,000    (706,000 )   356,000     (45,000 )   130,000     (83,000 )   57,000     (24,000 )   (116,000 )   (358,000 )   (45,000 )   —       47,000     (83,000 )
                                                                                   

As restated

   490,000    23,000     (3,244,000 )   (1,503,000 )   (34,929,000 )   48,470,000     2,503,000     1,474,000     (116,000 )   10,522,000     (14,113,000 )   (6,000,000 )   12,835,000     9,827,000  
                                                                                   

% Difference

                      3.3 %   0.3 %   0.0 %   0.4 %   0.8 %

3 mo ended 9/30/06:

                             

As previously reported

   266,000    776,000     (3,600,000 )   (2,627,000 )   (35,034,000 )   52,295,000     959,000     379,000     —       8,444,000     (15,364,000 )   (6,000,000 )   16,520,000     3,742,000  

adjustment

   336,000    (672,000 )   451,000     (45,000 )   130,000     (200,000 )   12,000     (34,000 )   (95,000 )   (336,000 )   (45,000 )   —       (70,000 )   (117,000 )
                                                                                   

As restated

   602,000    104,000     (3,149,000 )   (2,672,000 )   (34,904,000 )   52,095,000     971,000     345,000     (95,000 )   8,108,000     (15,409,000 )   (6,000,000 )   16,450,000     3,625,000  
                                                                                   

% Difference

                      4.0 %   0.3 %   0.0 %   0.4 %   3.1 %

Year ended 9/30/06:

                             

As previously reported

   266,000    776,000     (3,600,000 )   (2,627,000 )   (35,034,000 )   52,295,000     3,405,000     1,877,000     —       8,444,000     (15,364,000 )   (6,000,000 )   16,520,000     13,652,000  

adjustment

   336,000    (672,000 )   451,000     (45,000 )   130,000     (200,000 )   69,000     (58,000 )   (211,000 )   (336,000 )   (45,000 )   —       (70,000 )   (200,000 )
                                                                                   

As restated

   602,000    104,000     (3,149,000 )   (2,672,000 )   (34,904,000 )   52,095,000     3,474,000     1,819,000     (211,000 )   8,108,000     (15,409,000 )   (6,000,000 )   16,450,000     13,452,000  
                                                                                   

% Difference

                      4.0 %   0.3 %   0.0 %   0.4 %   1.5 %

3 mo ended 12/31/06:

                             

As previously reported

   639,000    1,472,000     (6,000,000 )   (2,921,000 )   (61,226,000 )   76,245,000     1,272,000     2,035,000     —       8,960,000     (17,034,000 )   —       14,074,000     23,950,000  

adjustment

   438,000    (1,443,000 )   732,000     (45,000 )   626,000     (308,000 )   13,000     (25,000 )   (96,000 )   (1,005,000 )   (45,000 )   —       318,000     (108,000 )
                                                                                   

As restated

   1,077,000    29,000     (5,268,000 )   (2,966,000 )   (60,600,000 )   75,937,000     1,285,000     2,010,000     (96,000 )   7,955,000     (17,079,000 )   —       14,392,000     23,842,000  
                                                                                   

% Difference

                      11.2 %   0.3 %   0.0 %   2.3 %   0.5 %

3 mo ended 3/31/07:

                             

As previously reported

   522,000    954,000     (5,596,000 )   (3,525,000 )   (62,721,000 )   81,695,000     1,889,000     1,556,000     (478,000 )   8,439,000     (20,872,000 )   —       18,029,000     5,450,000  

adjustment

   422,000    (918,000 )   424,000     —       626,000     (554,000 )   (450,000 )   (176,000 )   380,000     (496,000 )   —       —       72,000     (246,000 )
                                                                                   

As restated

   944,000    36,000     (5,172,000 )   (3,525,000 )   (62,095,000 )   81,141,000     1,439,000     1,380,000     (98,000 )   7,943,000     (20,872,000 )   —       18,101,000     5,204,000  
                                                                                   

% Difference

                      5.9 %   0.0 %   0.0 %   0.4 %   4.5 %

6 mo ended 3/31/07:

                             

As previously reported

   522,000    954,000     (5,596,000 )   (3,525,000 )   (62,721,000 )   81,695,000     3,160,000     3,591,000     (478,000 )   8,439,000     (20,872,000 )   —       18,029,000     29,400,000  

adjustment

   422,000    (918,000 )   424,000     —       626,000     (554,000 )   (437,000 )   (201,000 )   284,000     (496,000 )   —       —       72,000     (354,000 )
                                                                                   

As restated

   944,000    36,000     (5,172,000 )   (3,525,000 )   (62,095,000 )   81,141,000     2,723,000     3,390,000     (194,000 )   7,943,000     (20,872,000 )   —       18,101,000     29,046,000  
                                                                                   

% Difference

                      5.9 %   0.0 %   0.0 %   0.4 %   1.2 %

3 mo ended 6/30/07:

                             

As previously reported

   520,000    891,000     (5,411,000 )   (4,480,000 )   (62,789,000 )   93,738,000     160,000     458,000     (112,000 )   6,932,000     (31,524,000 )   —       30,003,000     12,043,000  

adjustment

   —      (891,000 )   420,000     (70,000 )   626,000     (85,000 )   388,000     149,000     (68,000 )   (891,000 )   (70,000 )   —       541,000     469,000  
                                                                                   

As restated

   520,000    —       (4,991,000 )   (4,550,000 )   (62,163,000 )   93,653,000     548,000     607,000     (180,000 )   6,041,000     (31,594,000 )   —       30,544,000     12,512,000  
                                                                                   

% Difference

                      12.9 %   0.2 %   0.0 %   1.8 %   3.9 %

9 mo ended 6/30/07:

                             

As previously reported

   520,000    891,000     (5,411,000 )   (4,480,000 )   (62,789,000 )   93,738,000     3,320,000     4,049,000     (590,000 )   6,932,000     (31,524,000 )   —       30,003,000     41,443,000  

adjustment

   —      (891,000 )   420,000     (70,000 )   626,000     (85,000 )   (49,000 )   (52,000 )   216,000     (891,000 )   (70,000 )   —       541,000     115,000  
                                                                                   

As restated

   520,000    —       (4,991,000 )   (4,550,000 )   (62,163,000 )   93,653,000     3,271,000     3,997,000     (374,000 )   6,041,000     (31,594,000 )   —       30,544,000     41,558,000  
                                                                                   

% Difference

                      12.9 %   0.2 %   0.0 %   1.8 %   0.3 %